Trends in Anti-VEGF Intravitreal Injections over 4 Years in a Large Retinal Practice

Byooviz (ranibizumab-nuna) - Samsung, AffaMed Therap, Biogen

Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva

Vabysmo (faricimab-svoa) - Roche

Beovu (brolucizumab-dbll) - Novartis

Matthew Wilneff1,4; Alex Miller2,4; Shannon Wuller3; Harrison Dean Sciulli4

Apr 15, 2024